The tumor size was significantly greater in the TERT promoter mutation-positive group (32.1 ± 15.7 mm) than in the BRAFV600E alone (19.8 ± 11.4 mm, p < 0.001) or mutation-negative group (22.6 ± 15.3 y, p = 0.001) (Table 1). The gene discussed is TERT; the disease is neoplasm.